v3.25.0.1
Revenues (Tables)
 12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Summary of Revenues by Collaboration, Category of Revenue and Method of Recognition
The following table summarizes our revenues by collaboration, category of revenue, and the method of recognition (in millions):
Year Ended December 31,
Over timePoint in time202420232022
Gilead Collaboration
License and R&D services*$207 $75 $74 
R&D services*8 4 — 
Access rights*28 33 33 
Taiho Collaboration
License revenue*15 — — 
Other*— 5 5 
Total revenues$258 $117 $112 
Total revenues from collaborations$207 $80 $74 
Total revenues from a customer$51 $37 $38 
Summary of Revenue Recognized as a Result of Changes in Deferred Revenue
The following table summarizes the revenue recognized as a result of changes in the deferred revenue balance (in millions):
Year Ended December 31,
202420232022
Revenue recognized from amounts in deferred revenue at the beginning of the period$243 $108 $112 
Summary of Transaction Price and Allocation of Transaction Price to the Performance Obligations
The following table summarizes the transaction price (in millions):
Transaction priceAmount
Premium from Third Stock Purchase Agreement Amendment$87 
Option continuation payment received in the third quarter of 2024100 
Deferred revenue as of January 2024335 
Total transaction price$522 
The following table summarizes the allocation of the transaction price to the performance obligations (in millions):
Allocation to performance obligationsDistinctCombinedAmount
Etrumadenant - License and R&D services*$210 
Quemliclustat - License and R&D services*168
Domvanalimab - R&D services*33
Access rights*57
Option continuation periods*20
Rights to certain studies*34
Total allocated transaction price$522 
The following table summarizes the allocation of the transaction price to the performance obligations (in millions):
Allocation to performance obligationsDistinctAmount
Inflammation target 1 - R&D services*$18 
Inflammation target 2 - R&D services*17
Total allocated transaction price$35